- Admin
- #1
Dublin, Dec. 15, 2020 (GLOBE NEWSWIRE) -- The "Immunohematology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering. The global immunohematology market grew at a CAGR of around 6% during 2014-2019. Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT). The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices. Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further. Looking forward, the publisher expects the global immunohematology market to continue its moderate growth during the next five years. Breakup by Product: * Analyzing Systems * Reagents and ConsumablesBreakup by Technology: * Biochips * Gel Cards * Microplates * Polymerase Chain Reaction * Erythrocyte-Magnetized Technology (EMT) * OthersBreakup by Application: * Blood-Related Disorders * HIV * Hepatitis * Blood Transfusion * OthersBreakup by End-User: * Hospitals * Blood Banks * Diagnostic Laboratories * OthersCompetitive Landscape: The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., etc. Key Questions Answered in This Report: * How has the global immunohematology market performed so far and how will it perform in the coming years? * What are the key regional markets? * What has been the impact of COVID-19 on the global immunohematology market? * What is the breakup of the market based on the product? * What is the breakup of the market based on the technology? * What is the breakup of the market based on the application? * What is the breakup of the market based on the end-user? * What are the various stages in the value chain of the industry? * What are the key driving factors and challenges in the industry? * What is the structure of the global immunohematology market and who are the key players? * What is the degree of competition in the industry? Key Topics Covered: 1 Preface 2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology 3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends 5 Global Immunohematology Market 5.1 Market Overview 5.2 Market Performance 5.3 Impact of COVID-19 5.4 Market Forecast 6 Market Breakup by Product 6.1 Analyzing Systems 6.1.1 Market Trends 6.1.2 Market Forecast 6.2 Reagents and Consumables 6.2.1 Market Trends 6.2.2 Market Forecast 7 Market Breakup by Technology 7.1 Biochips 7.1.1 Market Trends 7.1.2 Market Forecast 7.2 Gel Cards 7.2.1 Market Trends 7.2.2 Market Forecast 7.3 Microplates 7.3.1 Market Trends 7.3.2 Market Forecast 7.4 Polymerase Chain Reaction 7.4.1 Market Trends 7.4.2 Market Forecast 7.5 Erythrocyte-Magnetized Technology (EMT) 7.5.1 Market Trends 7.5.2 Market Forecast 7.6 Others 7.6.1 Market Trends 7.6.2 Market Forecast 8 Market Breakup by Application 8.1 Blood-Related Diseases 8.1.1 Market Trends 8.1.2 Market Forecast 8.2 HIV 8.2.1 Market Trends 8.2.2 Market Forecast 8.3 Hepatitis 8.3.1 Market Trends 8.3.2 Market Forecast 8.4 Blood Transfusion 8.4.1 Market Trends 8.4.2 Market Forecast 8.5 Others 8.5.1 Market Trends 8.5.2 Market Forecast 9 Market Breakup by End-User 9.1 Hospitals 9.1.1 Market Trends 9.1.2 Market Forecast 9.2 Blood Banks 9.2.1 Market Trends 9.2.2 Market Forecast 9.3 Diagnostic Laboratories 9.3.1 Market Trends 9.3.2 Market Forecast 9.4 Others 9.4.1 Market Trends 9.4.2 Market Forecast 10 Market Breakup by Region 10.1 North America 10.1.1 United States 10.1.1.1 Market Trends 10.1.1.2 Market Forecast 10.1.2 Canada 10.1.2.1 Market Trends 10.1.2.2 Market Forecast 10.2 Asia Pacific 10.2.1 China 10.2.1.1 Market Trends 10.2.1.2 Market Forecast 10.2.2 Japan 10.2.2.1 Market Trends 10.2.2.2 Market Forecast 10.2.3 India 10.2.3.1 Market Trends 10.2.3.2 Market Forecast 10.2.4 South Korea 10.2.4.1 Market Trends 10.2.4.2 Market Forecast 10.2.5 Australia 10.2.5.1 Market Trends 10.2.5.2 Market Forecast 10.2.6 Indonesia 10.2.6.1 Market Trends 10.2.6.2 Market Forecast 10.2.7 Others 10.2.7.1 Market Trends 10.2.7.2 Market Forecast 10.3 Europe 10.3.1 Germany 10.3.1.1 Market Trends 10.3.1.2 Market Forecast 10.3.2 France 10.3.2.1 Market Trends 10.3.2.2 Market Forecast 10.3.3 United Kingdom 10.3.3.1 Market Trends 10.3.3.2 Market Forecast 10.3.4 Italy 10.3.4.1 Market Trends 10.3.4.2 Market Forecast 10.3.5 Spain 10.3.5.1 Market Trends 10.3.5.2 Market Forecast 10.3.6 Russia 10.3.6.1 Market Trends 10.3.6.2 Market Forecast 10.3.7 Others 10.3.7.1 Market Trends 10.3.7.2 Market Forecast 10.4 Latin America 10.4.1 Brazil 10.4.1.1 Market Trends 10.4.1.2 Market Forecast 10.4.2 Mexico 10.4.2.1 Market Trends 10.4.2.2 Market Forecast 10.4.3 Others 10.4.3.1 Market Trends 10.4.3.2 Market Forecast 10.5 Middle East and Africa 10.5.1 Market Trends 10.5.2 Market Breakup by Country 10.5.3 Market Forecast 11 SWOT Analysis 11.1 Overview 11.2 Strengths 11.3 Weaknesses 11.4 Opportunities 11.5 Threats 12 Value Chain Analysis 13 Porters Five Forces Analysis 13.1 Overview 13.2 Bargaining Power of Buyers 13.3 Bargaining Power of Suppliers 13.4 Degree of Competition 13.5 Threat of New Entrants 13.6 Threat of Substitutes 14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Abbott 14.3.1.1 Company Overview 14.3.1.2 Product Portfolio 14.3.1.3 Financials 14.3.1.4 SWOT Analysis 14.3.2 Antisel 14.3.2.1 Company Overview 14.3.2.2 Product Portfolio 14.3.3 BD (Becton Dickinson and Company) 14.3.3.1 Company Overview 14.3.3.2 Product Portfolio 14.3.3.3 Financials 14.3.3.4 SWOT Analysis 14.3.4 Beckman Coulter Inc. (Danaher Corporation) 14.3.4.1 Company Overview 14.3.4.2 Product Portfolio 14.3.4.3 SWOT Analysis 14.3.5 Bio-Rad Laboratories Inc. 14.3.5.1 Company Overview 14.3.5.2 Product Portfolio 14.3.5.3 Financials 14.3.5.4 SWOT Analysis 14.3.6 F. Hoffmann-La Roche Ltd. 14.3.6.1 Company Overview 14.3.6.2 Product Portfolio 14.3.6.3 SWOT Analysis 14.3.7 Grifols S.A. 14.3.7.1 Company Overview 14.3.7.2 Product Portfolio 14.3.7.3 Financials 14.3.7.4 SWOT Analysis 14.3.8 Merck KGaA 14.3.8.1 Company Overview 14.3.8.2 Product Portfolio 14.3.8.3 Financials 14.3.8.4 SWOT Analysis 14.3.9 MTC Invitro Diagnostics AG 14.3.9.1 Company Overview 14.3.9.2 Product Portfolio 14.3.9.3 Financials 14.3.10 Ortho-Clinical Diagnostics Inc (The Carlyle Group) 14.3.10.1 Company Overview 14.3.10.2 Product Portfolio 14.3.10.3 SWOT Analysis 14.3.11 Thermo Fisher Scientific Inc. 14.3.11.1 Company Overview 14.3.11.2 Product Portfolio 14.3.11.3 Financials 14.3.11.4 SWOT Analysis For more information about this report visit https://www.researchandmarkets.com/r/k8p07rResearch and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900